Properties of the rat hepatic cholecalciferol 25-hydroxylase have been studied. An assay system has been developed in which 25-hydroxycholecalciferol production is linear for at least 2h in both homogenates and microsomal fraction. Furthermore, the initial reaction velocity is linearly related to the amount of liver tissue or microsomal fraction. This enzyme system also metabolizes an analogue of cholecalciferol, namely dihydrotachysterol3, into 25-hydroxydihydrotachysterol3. The 25-hydroxylase is in the microsomal fraction and not in mitochondria. It has a Km of 44nM for cholecalciferol and 360nM for dihydrotachysterol3. Its activity is not altered by dietary concentrations of calcium and phosphorus. Vitamin D-deficient rats have higher activities of the hepatic 25-hydroxylase than those receiving 25ng of cholecalciferol daily. The 25-hydroxylase is inhibited by metyrapone. An atmosphere of CO/02 (9: 1, v/v) inhibits the reaction by 87 %. This inhibition is partially reversed by white light. Additionally, cholecalciferol and 25-hydroxycholecalciferol competitively inhibit aminopyrine demethylase. These results support the idea that the cholecalciferol 25-hydroxylase is a cytochrome P-450-dependent mono-oxygenase.
Previous reports have established that cholecalciferol must be metabolically activated to 25(OH)D3 in the liver and subsequently in the kidney to 1,25-(OH)2D3 before it can manifest its physiological functions (DeLuca, 1974; Kodicek, 1974; DeLuca & Schnoes, 1976) . Thus the 25-hydroxylase is an important enzyme in the activation of cholecalciferol. Little is known concerning the properties of this enzyme, mostly because minimal activity is exhibited when the enzyme is assayed in vitro. Horsting & DeLuca (1969) first reported the ability of rat liver homogenates to convert cholecalciferol into 25-(OH)D3 when supported by added glucose 6-phosphate and Mg2+ utilizing the endogenous glucose 6-phosphate dehydrogenase. It was later reported (Bhattacharyya & DeLuca, 1974 ) that the enzyme is predominantly found in the microsomal fraction of rat liver homogenates and requires the soluble fraction of the cell for maximal activity. The cytosol contains a heat-labile factor that both protects the substrate and stimulates conversion of cholecalciferol into 25(OH)D3 and may well be analogous to the system described for cholesterol biosynthesis and for Abbreviations used: 25(OH)D3, 25-hydroxycholecalciferol; 1,25(OH)2D3, 1,25-dihydroxycholecalciferol; h.p.l.c., high-pressure liquid chromatography. Vol. 184 bile acid biosynthesis (Ritter & Dempsey, 1971; Scallen et al., 1971; Grabowski et al., 1976) . In addition, some 25-hydroxylation was observed in the mitochondrial fraction, especially at high substrate concentration (Bhattacharyya & DeLuca, 1973) , as well as production of a more-polar metabolite not identical with 25(OH)D3. Further studies (Bhattacharyya & DeLuca, 1973; Horsting & DeLuca, 1969) with inhibitors of mixed-function oxidase systems could not detect any involvement of cytochrome P-450 in this hydroxylation reaction. Because of the biological requirements of the enzyme for activity, i.e. 02 and nicotinamide nucleotides, we have pursued a thorough search for possible mechanisms involved in the mixed-function oxidase. Madhok et al. (1978) found incorporation of 1802 into the 25-position of cholecalciferol to form 25(8OH)D3 by using rat liver postmitochondrial supernatant. Bjorkhem & Holmberg (1978) , utilizing rat liver mitochondrial fraction alone and with their massfragmentographic assay, have suggested that the 25-hydroxylase is cytochrome P-450-dependent. Cinti et al. (1976) demonstrated that 25(OH)D3 is an inhibitor of aminopyrine N-demethylase, a cytochrome P-450-dependent microsomal reaction in the rat liver. These are a few indications of the involvement of cytochrome P-450 as a terminal oxidase in the 25-hydroxylation of cholecalciferol by rat liver microsomal fraction.
The purpose of the present paper is to report the properties of this system, to demonstrate its microsomal location and to report substantial evidence of the participation of cytochrome P-450 . It was further purified before use by passage through a column (1cm x 60cm) of Lipidex 5000 with hexane/chloroform (9: 1, v/v) as solvent system. Elution was accomplished by using the same solvent system. A total of 50 fractions of 3 ml/fraction was obtained and the 25-hydroxydihydrotachysterol3 peak was pooled and used. Crystalline cholecalciferol, 25(OH)D3 and dihydrotachysterol3 were gifts of the Philips-Duphar Co., Weesp, The Netherlands. Metyrapone was a gift from CIBA-GEIGY Corporation. Aminopyrine was a gift from Dr. Elizabeth Jeffery, Department of Pharmacology, University of Minnesota, Minneapolis, MN, U.S.A. Other chemicals were purchased from Sigma Chemical Co. All solvents used were of analytical grade.
Animals
Unless otherwise stated, male weanling rats (Holtzman Co., Madison, WI, U.S.A.) were maintained in hanging wire cages and fed ad libitum a vitamin D-deficient 0.02% calcium diet for 3 weeks (Suda et al., 1970) .
Preparation ofsubcellularfractions
The rats were killed by cervical dislocation, and the livers were immediately removed and carefully separated from the adhering connective tissue. The livers were rinsed with ice-cold 0.25M-sucrose, transferred to an ice-cold Potter-Elvehjem homogenizer fitted with a Teflon pestle, and homogenized in 3 vol. of the sucrose. The homogenate was centrifuged at 800g at 4°C for 10min to sediment a crude nuclear pellet by using a Lourdes centrifuge equipped with a 9 RA rotor. The resulting supernatant was centrifuged for 15min at 100OOg to sediment most of the mitochondrial fraction. In experiments where a pure mitochondrial fraction was needed, the method of DeLuca et al. (1960) (Bhattacharyya & DeLuca, 1974) . To a 125 ml Erlenmeyer flask was added 2.5 ml of cell fraction suspension, 2.5 ml of cytoplasmic fraction (or simply 4-5 ml of liver homogenate), 2.5 ml of buffer cofactor solution (O.1 Mpotassium phosphate buffer,0.4mM-NADP+, 160mM-nicotinamide, 20mM-ATP and 22.4mM-glucose 6-phosphate adjusted to pH7.4), 2. (Fig. 1) . The 25-hydroxydihydrotachysterol3 and dihydrotachysterol3 assume the same positions with this chromatographic system as 25(OH)D3 and cholecalciferol respectively. After each group of determinations, the columns were stripped with 50ml of hexane/chloroform (4:1, v/v). They were regenerated by washing with 50ml of hexane/chloroform (9: 1, v/v) before applying a new sample. A column can be used several times before it must be discarded. The identity of the product was positively identified by co-chromatography with authentic 25(OH)D3 or dihydrotachysterol3 on h.p.l.c. as described by Jones & DeLuca (1975) . No other metabolites were observed in these studies.
Inhibition of 25-hydroxylase by CO and reversal of inhibition by white light Gases like CO and N2 were made free of contaminating 02 by passage through a solution of 10% pyrogallol in 5% KOH. Traces of the alkali were removed by-passage of the deoxygenated gases through 19 mM-Na2S203 and 50mM-Tris/HCI, pH 8.0. Purified gases were finally stored in reservoirs fitted with rubber septa. Gases were removed from the reservoirs by means of a gas-tight syringe. Fraction no. Fractions (3 ml) were collected from the column and the fractions were analysed for radioactivity. Cholecalciferol (D3) (tubes 11-22) was eluted first followed by 25(OH)D3 (tubes 32-47). Recovery of added radioactivity was 100%.
projection lamp (with intensity of77.5 klx as measured by a Gossen light-meter) equipped with focusing lens was used as the source of white light. The light was allowed to pass through a thin-glass window of a polyacrylic temperature-regulated water bath, and was reflected into the vessel by a mirror. The incubation mixture in a 25ml Erlenmeyer flask was illuminated, therefore, from the bottom.
Assay of microsomal aminopyrine N-demethylase activity
The assay is an adaptation of the procedure of Sladek & Mannering (1969a (Fig. 2a) . Enzyme activity was also linear with up to 20mg of microsomal protein (Fig. 2b) . The Km for the rat liver microsomal conversion of cholecalciferol into 25(OH)D3 was 44 nM as calculated by the method of least squares (Fig. 2c) .
Comparison of the 25-hydroxylation of cholecalciferol and dihydrotachysterol3 by liver subcellular fractions from vitamin D-deficient and vitamin D-supplemented rats
The Km for the rat liver microsomal conversion of dihydrotachysterol3 into 25-hydroxydihydrotachysterol3 was 360nM, which is 8-fold greater than that found for cholecalciferol (Fig. 2c) . We observed that in both vitamin D-deficient and vitamin D-supplemented rats, 25-hydroxylase activity for cholecalciferol (Table 1 ) and dihydrotachysterol3 is located in the microsomal fraction, requiring for full activity the soluble fraction of the homogenate in addition to 02 and NADPH. As found before (Bhattacharyya & DeLuca, 1973 , microsomal conversion of cholecalciferol into 25(OH)D3 was decreased to almost half the activity on supplementation of vitamin D-deficient rats with 1 unit of cholecalciferol/ day for 3 weeks (Table 2) . Enzyme activity responsible for converting dihydrotachysterol3 into 25-hydroxydihydrotachysterol3 on the other hand is not affected by cholecalciferol supplementation of rats. The product of microsomal hydroxylation of cholecalciferol was confirmed as 25(OH)D3 by h.p.l.c. (Fig. 3) . Similarly the product obtained from mitochondrial Fraction no. Diet composition 1.2% Ca, 1.2% P+cholecalciferol 1.2% Ca, 0.1% P 0.47% Ca, 0.3% P 1.2% Ca, 0.3% P 0.02% Ca, 0.3% P 0.47% Ca, 0.3% P 0.47 % Ca, 0.3 % P+cholecalciferol 0.02% Ca, 0.3% P 0.02% Ca, 0.3 % P+cholecalciferol 12 Fig. 3 . Identification of the metabolite produced on incubation of cholecalciferol and dihydrotachysterol3 with the rat liver microsomal system by h.p.l.c. The metabolites produced on microsomal incubation of cholecalciferol and dihydrotachysterol3 were pooled, dried under N2, dissolved in 20p1 of 4% propan-2-ol/hexane and injected into an h.p.l.c. apparatus by using a Zorbax-SIL column (0.46cm x 25 cm) (Dupont, Wilmington, DE, U.S.A.) for cholecalciferol and a Partisil X-10 column (0.45 cmx 50cm) (Waters Associates, Milford, MA, U.S.A.) for dihydrotachysterol3 (25-OH-DHT3). In either case elution was accomplished with 4% propan-2-ol/ hexane, collecting 2.4ml/fraction at 6900kPa. The 25(OH)D3 arising from cholecalciferol incubations (a) was identified by its co-chromatography with authentic 25(OH)D3, whereas the 25-hydroxydihydrotachysterol3 arising from dihydrotachysterol3 incubations (b) was identified by making a separate run of authentic radioactive 25-hydroxydihydrotachysterol3 and noting the position occupied compared with the incubation product. [Metyraponel (mM) Fig. 4 . Inhibition of 25-hydroxylase by various concentrations ofmetyrapone Various concentrations from 0.5mM to 5mM of metyrapone were added to the incubation vessels. Two separate experiments were conducted by using either 21.2nM-cholecalciferol (D3) or 42.5nM-cholecalciferol. Microsomal protein (20mg) and cytosol (52.5mg of protein) were added to each incubation mixture. The incubation mixtures were as described in the Experimental section.
incubation of the microsomal fraction with dihydrotachysterol3, as determined by a similar run on h.p.l.c. of authentic 25-hydroxydihydrotachysterol3 (Fig. 3b) . Any metabolite observed with mitochondrial incubations of dihydrotachysterol3 proved to be 25-hydroxydihydrotachysterol3, and no other metabolite was observed. Steenbock (1923) ; (b) 1.2% calcium, 0.1 % phosphorus diet (low-phosphorus diet); (c) 0.47 % calcium, 0.3 % phosphorus diet (normal calcium and phosphorus diet); (d) 1.2% calcium, 0.3 % phosphorus diet (high-calcium diet); (e) 0.02 % calcium and 0.3 % phosphorus diet (low-calcium diet) for 3 weeks. As shown in Table 2 , higher enzymic activity is observed in rats on vitamin Ddeficient diets compared with that of the rats given a stock diet containing vitamin D. However, no influence of dietary calcium or phosphorus could be detected on the 25-hydroxylase activity. In another experiment, the intraperitoneal injection of 1 unit of cholecalciferol/day to rats fed various amounts of calcium caused an average decrease of 30% in 25-hydroxylase activity compared with that of vitamin D-deficient controls (Table 2) . The procedure is an adaptation of that of Sladek & Mannering (1969b) . Formaldehyde is measured by the method of Nash (1953 Inhibition of rat liver 25-hydroxylase by CO and reversal ofinhibition by white light
As shown in Fig. 5 , maximum inhibition (87 %) of cholecalciferol 25-hydroxylase was observed when incubation was carried out in an atmosphere of 02/CO (9: 1, V/V). Incubations in an atmosphere of decreasing ratios of 02/CO resulted in a linear decrease in enzyme activity as shown in Fig. 5 . Inhibition by CO is reversed by 32 % on exposure of the preincubated medium to white light (Table 3) . Effect of additions in vitro of cholecalciferol on rat liver microsomal aminopyrine N-demethylase activity As shown in Fig. 6 , addition of 123nM-25(OH)D3 to the aminopyrine N-demethylase system increased the apparent Km of the enzyme from 1.72mM to 2.62mM, i.e. 52 % inhibition of enzyme activity, whereas addition of 266nM-cholecalciferol to the enzyme system increased the apparent Km of the reaction from 1.32mM to 2.12mM, i.e. 61 % inhibition of enzyme activity. Inhibition is apparently competitive in nature.
Discussion
To study the properties of the cholecalciferol 25-hydroxylase we developed a whole homogenate system that produces 25(OH)D3 linearly for 5h and in which reaction rate is linearly related up to 1 g of liver tissue. With this system, the Kmfor cholecalciferol is 60nM.
There has been some controversy regarding the subcellular localization of the 25-hydroxylase. ConVol. 184 trary to other investigators (Bjorkhem & Holmberg, 1978) we could not detect any succinate-supported mitochondrial activity, nor could we observe significant activity without the cytosolic fraction added to the microsomal fraction. These results agree with and support the previous demonstration that the 25-hydroxylase is microsomal (Bhattacharyya & DeLuca, 1974) . Any 25-hydroxylase activity found in the mitochondrial fraction under our conditions is likely to be the result of microsomal contamination. This may account for the results of Bjorkhem & Holmberg (1978) . We have not, however, exactly reproduced their experiments. In addition, there appears to be an obligatory requirement for the soluble fraction of the rat liver homogenates for maximal activity to be observed with the microsomal fraction (Bhattacharyya & DeLuca, 1974) . Previous work (Bhattacharyya & DeLuca, 1974) has shown that cholecalciferol is easily degraded to unknown substances when cytosol is excluded from the medium. Dihydrotachysterol3, when incubated with subcellular fractions in the absence of cytosol, is also degraded (T. C. Madhok & H. F. DeLuca, unpublished work) . It is possible that the liver microsomal lipidperoxidation system may be responsible for the degradation. This is supported by the observation that NN'-diphenyl-p-phenylenediamine, a known inhibitor of that system, will block this degradation of cholecalciferol. Bhattacharyya & DeLuca (1974) first found that if cholecalciferol is incubated with microsomal fraction alone, addition ofNN'-diphenylp-phenylenediamine prevents destruction of cholecalciferol, the cholecalciferol being recovered unchanged. Thus Bjorkhem & Holmberg (1978) might not have observed reliable microsomal activity without the addition of cytosol. However, we cannot exclude the possibility that saturating amounts of cholecalciferol and a shorter time of incubation, as was adopted by Bjorkhem & Holmberg (1978) , might obviate the problem of the destruction of the substrate.
The 25-hydroxylation of dihydrotachysterol3, a reduction product of cholecalciferol known to have cholecalciferol-like biological activity, is apparently not regulated (Bhattacharyya & DeLuca, 1973) . It is important to discover whether the same enzyme hydroxylates both cholecalciferol and dihydrotachysterol3. Our results show that the microsomal fraction and not mitochondria are responsible for metabolizing dihydrotachysterol3 to 25-hydroxydihydrotachysterol3. Again, cytosol is an obligatory requirement for full activity. As demonstrated previously (Bhattacharyya & DeLuca, 1973) , the administration of vitamin D to rats did not affect the ability of the rat liver microsomal enzyme to convert dihydrotachysterol3 to 25-hydroxydihydrotachysterol3. The Km of the microsomal enzyme for dihydrotachysterol3 is 360nM, which is about 8-fold higher than that observed with cholecalciferol 25-hydroxylase.
Thus it is uncertain if the same enzyme hydroxylates both substances, but at least the idea that dihydrotachysterol3 is hydroxylated to 25-hydroxydihydrotachysterol3 in mitochondria can be excluded.
Neither dietary calcium nor dietary phosphorus seem to influence cholecalciferol 25-hydroxylase activity. Only feeding of cholecalciferol seems to affect enzyme activity. This phenomenon was discussed fully by Horsting & DeLuca (1969) . This suppression of enzyme activity by feeding of cholecalciferol to rats is still the subject of investigation and no firm explanation can be offered at this moment.
Cytochrome P-450 plays a major role in most biological hydroxylation reactions as the terminaloxygen-activating enzyme for such reactions. Mason (1957) introduced the term 'mixed function oxidase' for such enzymes catalysing the introduction of an atom of molecular oxygen into the substrate molecule concomitant with the oxidation of reduced nicotinamide nucleotide. Inasmuch as cholecalciferol 25-hydroxylase requires atmospheric 02, which is the source of the oxygen for the 25-hydroxy function and NADPH, we have carefully considered the possibility that cytochrome P450 participates in the 25-hydroxylation of cholecalciferol. Our results suggest the enzyme belongs to the mixed-function oxidase class. The evidence for participation of cytochrome P-450 in 25-hydroxylation reactions has been derived from (a) the inhibition of enzyme activity by CO, (b) photoreversibility of the CO inhibition, (c) the inhibition by drugs such as metyrapone, (d) the inhibition of other cytochrome P450-dependent reactions by cholecalciferol and 25(OH)D3 and (e) phenobarbital induction.
CO inhibition of mixed-function oxidase can be attributed to its binding to the cytochrome P-450 eliciting the typical absorption band at 450nm (Omura et al., 1965) . Such CO inhibition of biological reactions may be reversed by white light. Maximum reversal of CO inhibition is observed when light of 450nm is shone on the incubation mixture. Such a phenomenon was observed with the microsomal cholecalciferol 25-hydroxylase. Maximum inhibition by CO was 87 % with a ratio of 02/CO of 1: 9 (v/v). This inhibition by CO was reversed by 32 % by white light from a high-intensity projection lamp. Bhattacharyya & DeLuca (1974) failed to observe significant inhibition of the cholecalciferol 25-hydroxylation with 20% 02 and 80 % CO. Only 10 % inhibition was observed with their concentration of CO in the present study with 20% 02, whereas CO caused 87% inhibition when 10% 02 was present. Therefore Bhattacharyya & DeLuca (1974) failed to observe significant inhibition because of the oxygen tension used. Metyrapone is known to be an inhibitor of both microsomal and mitochondrial hydroxylation reactions (Hildebrandt, 1972; Jefcoate et al., 1973) . Experiments revealed a sensitivity of the cholecalciferol 25-hydroxylase system to metyrapone (K, of 3mm for 21.2nM-cholecalciferol and a K1 of 1.95mM for 42.5 nM-cholecalciferol). Another cholecalciferol hydroxylase, chick kidney mitochondrial 25(OH)D3 1 a-hydroxylase, has been extensively studied, purified and also found to be mediated by cytochrome P-450 (Ghazarian et al., 1974) . Metyrapone and also aminoglutethemide inhibit the 25(OH)D3 la-hydroxylase in a competitive manner. These inhibitors had not been tested by Bhattacharyya & DeLuca (1974) .
The use of 25(OH)D3 and cholecalciferol as possible inhibitors of the cytochrome P-450 microsomal aminopyrine N-demethylation reaction was investigated. As was seen by Cinti et al. (1976) Another line of evidence was the use of the well known inducer of cytochrome P-450, phenobarbital. In our previous work, we used the microsomal system together with the cytosol. The chromatogram obtained from phenobarbital-treated samples showed 50% recovery of the radioactive material from the column. Besides, four peaks were obtained: (1) a large non-polar peak in the region of the esters; (2) two peaks of almost equal intensity, one in the region of cholecalciferol and the other appearing as a shoulder on the cholecalciferol peak; (3) a fourth peak in the region of 25(OH)D3. If incubations were done in the presence of NN'-diphenyl-p-phenylenediamine, the chromatogram appeared similar to the one obtained from control experiment and little increase in activity that could be attributed to phenobarbital was noted (T. C. Madhok & H. F. DeLuca, unpublished work). Several explanations can be offered: (1) phenobarbital induces a microsomal system responsible for the degradation of cholecalciferol that is inhibited by NN'-diphenyl-pphenylenediamine; (2) phenobarbital induces further metabolism of 25(OH)D3 to unknown metabolites, either more polar or less polar or both; (3) phenobarbital is affecting the cytosolic protein and not the microsomal protein. We cannot at this time deduce which possibility is correct.
Intraperitoneal administration of phenobarbital to vitamin D-deficient calcium-deficient rats and also normal rats (T. C. Madhok & H. F. DeLuca, un- published work) produced a slight increase in liver microsomal 25-hydroxylase. This is similar to the findings of Bjorkhem & Holmberg (1978) who demonstrated a 2-fold increase in rat liver 25-hydroxylation of cholecalciferol. Many investigators 1979 have shown that multiple forms of cytochrome P-450 exist in the livers of several species. These haemoproteins were distinguished by their immunological response to specific antibodies, their catalytic behaviour, spectral properties and also with various inducers that became the basis for their separation, and purification to homogeneity (Sladek & Mannering, 1966 , 1969b Alvares et al., 1967 Alvares et al., , 1968 Hildebrandt et al., 1968; Comai & Gaylor, 1973; Thomas et al., 1976) . Therefore it is possible that although phenobarbital behaves as a universal inducer for a multitude of microsomal hydroxylating systems, it may not be the right inducer for the rat liver microsomal 25-hydroxylase (Ernster & Orrenius, 1965) . These findings therefore necessitate investigations with other drug inducers to confirm this hypothesis. The evidence reported in the present paper supports the concept that the microsomal 25-hydroxylation of cholecalciferol is a cytochrome P-450-dependent system. These results provide an impetus to attempt solubilization, purification and reconstitution of the components of this system that would provide rigorous proof of the nature of this hydroxylase.
